High variability of drug exposure: a biopharmaceutic risk factor for chronic rejection.
Kahan
B D
BD
Department of Surgery, University of Texas Medical School at Houston 77030, USA.
D016572:Cyclosporine / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006084:Graft Rejection / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D012307:Risk Factors; D016559:Tacrolimus / Q000493:pharmacokinetics / Q000627:therapeutic use; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D016559:Tacrolimus